Literature DB >> 8969335

Psychological factors in intensive management of insulin-dependent diabetes mellitus.

G J Strauss1.   

Abstract

With the publication of the DCCT results in 1993, hope has been given to patients with type I diabetes that blindness, kidney failure, and neuropathies are not necessarily what awaits them. However, to assume that diabetes is simply a disease that can be controlled "if only the patient would be compliant" is an incredibly naive way to approach treatment. Practitioners need to be keenly aware of not only the complexities of intensive management of type I diabetes but perhaps more importantly the numerous psychological factors that determine whether treatment adherence will occur. Psychological issues such as patient perceptions of symptoms, fear, unawareness of symptoms because of autonomic dysregulation or cognitive decline, attitudes, and control issues need to be assessed. These issues can be assessed quite easily with questionnaires, scales, and interview schedules readily available to practitioners. Additionally, for those patients who may not be attuned to monitoring physiologic or cognitive cues, awareness training and other coping skills interventions are available that can be incorporated into existing diabetes education programs. A mutual effort by the patient and health-care provider team can lead to success in intensive management of IDDM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8969335

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  3 in total

1.  Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

2.  Posttraumatic Stress Related to Hyperglycemia: Prevalence in Adults with Type I Diabetes.

Authors:  Chelsea P Renna; Bret A Boyer; Maurice F Prout; Gary Scheiner
Journal:  J Clin Psychol Med Settings       Date:  2016-09

3.  The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: a placebo-controlled, multicentre study.

Authors:  Per Bech; Robert Moses; Ramón Gomis
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.